| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,073,500 | 2,066,100 | 2,060,500 | 1,244,400 | | Cost of Revenue | 1,207,500 | 1,226,900 | 1,208,700 | 863,200 | | | Gross Profit | 866,000 | 839,200 | 851,800 | 381,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 292,800 | 215,800 | 217,500 | 182,700 | | Non Recurring | 157,500 | (137,800) | 36,200 | 172,500 | | Others | 173,000 | 240,600 | 245,100 | 137,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 387,000 | 520,600 | 353,000 | (111,600) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 114,100 | 2,000 | 900 | 800 | | Earnings Before Interest And Taxes | 356,800 | 522,600 | 353,900 | (110,800) | | Interest Expense | 144,700 | 150,600 | 153,500 | 66,800 | | Income Before Tax | 212,100 | 372,000 | 200,400 | (177,600) | | Income Tax Expense | 91,000 | 145,900 | 87,000 | (46,000) | | Minority Interest | (1,200) |
-
|
-
| (100) | | | | Net Income From Continuing Ops | 88,100 | 226,100 | 113,400 | (131,700) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 119,900 | 226,100 | 113,400 | (131,700) | | Preferred Stock And Other Adjustments | 600 | (200) | (400) |
-
| | | Net Income Applicable To Common Shares | $120,500 | $225,900 | $113,000 | ($131,700) |
|
0.16% Nasdaq 
0.37 (1.33%) 
Income Statement
